%0 Journal Article
%T Expression of MDM2 mRNA, MDM2, P53 and P16 Proteins in Urothelial Lesions in the View of the WHO 4th Edition Guidelines as a Molecular Insight towards Personalized Medicine
%A Amr El Kholy
%A Khalid Al Osili
%A Mohamed Badawy
%A Mona Magdy
%A Olfat Hammam
%A Tarek El LeitHy
%J Archive of "Open Access Macedonian Journal of Medical Sciences".
%D 2017
%R 10.3889/oamjms.2017.100
%X Here we imposed a multimarker molecular panel composed of P53, MDM2 protein & mRNA & P16 with the identification of sensitive and specific cut offs among the Egyptian urothelial carcinomas bilharzial or not emphasize the pathological and molecular classifications, pathways and prognosis as a privilege for adjuvant therapy
%K P53
%K MDM2mRNA
%K P16
%K urothelial
%K grade
%K bilharzia
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591584/